GOLDMAN SACHS GROUP INC - RANI THERAPEUTICS HLDGS INC ownership

RANI THERAPEUTICS HLDGS INC's ticker is and the CUSIP is 753018100. A total of 23 filers reported holding RANI THERAPEUTICS HLDGS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of RANI THERAPEUTICS HLDGS INC
ValueSharesWeighting
Q1 2023$173,025
+55.9%
33,532
+212.2%
0.00%
Q2 2022$111,000
-69.3%
10,739
-60.0%
0.00%
Q1 2022$362,000
-66.5%
26,820
-55.8%
0.00%
Q3 2021$1,081,00060,6490.00%
Other shareholders
RANI THERAPEUTICS HLDGS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Nan Fung Group Holdings Ltd 493,584$4,729,0003.02%
LASRY MARC 62,887$602,0001.16%
Alpha Square Group S LLC 101,603$973,0000.44%
Alphabet Inc. 714,471$6,845,0000.35%
TPB WEALTH ADVISORS 48,129$461,0000.22%
UNITED SERVICES AUTOMOBILE ASSOCIATION 481,300$4,606,0000.13%
ISLAY CAPITAL MANAGEMENT, LLC 9,611$92,0000.11%
Lafayette Investments 19,893$191,0000.06%
Canton Hathaway, LLC 16,200$155,0000.06%
Iowa State Bank 18,862$181,0000.05%
View complete list of RANI THERAPEUTICS HLDGS INC shareholders